FDA seeks input on rare-disease drug-development framework — sources for revision 1
U.S. Food and Drug Administration
Source date: 2026-10-14.
Supporting location: Initiative purpose, October28WhiteOakmeeting, planned furtherpublicinput andpossiblefutureguidance/regulatorychanges.
Source dates are distinct from Iliyn’s preparation date. Source statements do not independently prove underlying events. No full source articles or source photographs are reproduced.